Tyk2-IN-19

• UNSPSC Description:

  Tyk2-IN-19 (compound 1) is an orally active and blood-brain barrier (BBB) permeable Tyk2 inhibitor. Tyk2-IN-19 can be used for study of neurodegenerative diseases[1].

• Target Antigen:

  JAK

• Type:

  Reference compound

• Related Pathways:

  Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/tyk2-in-19.html

• Smiles:

  O=C(CC)C1=C(NC2=C(OC)C(C3=NN(C)N=C3)=CC=N2)C=C(NC(C4CC4)=O)N=C1

• Molecular Weight:

  421.45

• References & Citations:

  [1]Steven H. Spergel, et al. Substituted heterocyclic compounds. US20240124421A1. 2024-04-18.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2866415-98-5